G. Paiva

Concentric Needle Jitter in 97 Myasthenia Gravis Patients

E. Stålberg, J. Kouyoumdjian, G. Paiva, 2020, Frontiers in Neurology.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Time perception and age.

J. Kouyoumdjian, C. Graça, G. Paiva, 2016, Arquivos de neuro-psiquiatria.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

Problems in Comparing Jitter Values Obtained with Voluntary Activation and Electrical Stimulation.

Erik Stålberg, João Aris Kouyoumdjian, Gabriel Pina Paiva, 2018, Journal of neuromuscular diseases.